Literature DB >> 20848794

[Relationship between polymorphism of hypoxia inducible factor-1alpha and cervical cancer in Han population in Sichuan Province of China].

Dan Chai1, Ya-Li Chen, Ai Zheng, Yan-You Liu, Yan-Xia Chu, Ling Han.   

Abstract

OBJECTIVE: To investigate the relationship between single nucleotide polymorphism (SNP) of hypoxia inducible factor-1alpha (HIF-1alpha) C1772T and genetic susceptibility to and clinical-pathological features of cervical cancers in Han population in Sichuan province of China.
METHODS: A case control study was undertaken in Sichuan province of China, with 97 patients with uterine cervical cancer as case group and 117 negative for intraepithelial lesion or malignancy (NILM) patients as control group. Their gene types in HIF-1alpha C1772T were identified with a combination of polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP).
RESULTS: The distribution of the frequencies of T/T, T/C and C/C genotypes in the two groups differed significantly (P < 0.01); T allele frequency in the patients with cervical cancer was much higher than that in the controls (P < 0.01). There were no significant differences in the distributions of T/T, T/C and C/C genotypes among cervical cancer patients at different FIGO stages, pathological grading, stromal invasive depth, lymph node metastasis and vascular invasions (P > 0.05).
CONCLUSION: T/C and T/T genotypes of HIF-1alpha C1772T are genetic susceptibility factors for cervical cancer in Han population in Sichuan province of China. HIF-1alpha C1772T SNP probably has no relationship with clinical-pathological features of cervical cancer.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20848794

Source DB:  PubMed          Journal:  Sichuan Da Xue Xue Bao Yi Xue Ban        ISSN: 1672-173X


  8 in total

Review 1.  Genetic association between the HIF-1α P582S polymorphism and cervical cancer risk: a meta analysis.

Authors:  Jing Zhu; Xiang Cheng; Rongkai Xie; Zhengqiong Chen; Youfei Li; Guilan Lin; Jianmei Liu; Ying Yang
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

2.  Clinicopathological significance of hypoxia-inducible factor-1 alpha polymorphisms in cancers: evidence from a meta-analysis.

Authors:  Xin Hu; Sen Lin; Jun Zheng; Rui Guo; Hao Li; Chao You
Journal:  Tumour Biol       Date:  2013-07-16

Review 3.  The association between HIF-1α polymorphism and cancer risk: a systematic review and meta-analysis.

Authors:  Xin Hu; Yuan Fang; Jun Zheng; Yazhou He; Xin Zan; Sen Lin; Xi Li; Hao Li; Chao You
Journal:  Tumour Biol       Date:  2013-09-18

4.  Hypoxia-inducible factor-1α (HIF-1α) C1772T polymorphism significantly contributes to the risk of malignancy from a meta-analysis.

Authors:  Gang Wu; Wen-Feng Yan; Yuan-Zeng Zhu; Pei-Chun Sun
Journal:  Tumour Biol       Date:  2014-01-15

5.  Hypoxia-inducible factor-1α polymorphisms and risk of cancer metastasis: a meta-analysis.

Authors:  Qian Zhang; Yan Chen; Bin Zhang; Bin Shi; Wenjun Weng; Zhipeng Chen; Nannan Guo; Yibing Hua; Lingjun Zhu
Journal:  PLoS One       Date:  2013-08-28       Impact factor: 3.240

6.  HIF-1α rs11549465 C>T polymorphism contributes to increased cancer susceptibility: Evidence from 49 studies.

Authors:  Hu-Nian Li; Ting He; Yong-Jiu Zha; Fang Du; Jie Liu; Hui-Ran Lin; Wen-Zi Yang
Journal:  J Cancer       Date:  2019-10-15       Impact factor: 4.207

7.  The association between hypoxia-inducible factor-1 α gene C1772T polymorphism and cancer risk: a meta-analysis of 37 case-control studies.

Authors:  Pengfei He; Qi Han; Jiajia Liu; Dongjuan Liu; Xin Zhao; Ting Hu; Lu Jiang; Hongxia Dan; Xin Zeng; Jing Li; Jiayi Wang; Qianming Chen
Journal:  PLoS One       Date:  2013-12-18       Impact factor: 3.240

8.  HIF-1α 1772 C/T and 1790 G/A polymorphisms are significantly associated with higher cancer risk: an updated meta-analysis from 34 case-control studies.

Authors:  Xi Yang; Hong-Cheng Zhu; Chi Zhang; Qin Qin; Jia Liu; Li-Ping Xu; Lian-Jun Zhao; Qu Zhang; Jing Cai; Jian-Xin Ma; Hong-Yan Cheng; Xin-Chen Sun
Journal:  PLoS One       Date:  2013-11-18       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.